CAS: 1883510-31-3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
ML327 REF: AN-AG01EB2BCAS: 1883510-31-3 | 97% | 131,00 €~461,00 € | Vie 10 May 24 | |
ML327 REF: TM-T4252CAS: 1883510-31-3 | 99.48% | 49,00 €~791,00 € | Vie 17 May 24 | |
ML327 REF: 3D-IAD51031CAS: 1883510-31-3 | Min. 95% | A consultar | Vie 21 Jun 24 |
Ref: AN-AG01EB2B
1mg | 131,00 € | |
25mg | 170,00 € | |
50mg | 205,00 € | |
100mg | 461,00 € |
Entrega estimada en Estados Unidos, el Viernes 10 de Mayo de 2024
ML327
CAS:1883510-31-3
ML327 is a MYC blocker. ML327 can also de-repress E-cadherin transcription and reverse Epithelial-to-Mesenchymal Transition …
Fórmula:
C19H18N4O4
Pureza:
99.48%
Forma y color:
Solid
Peso molecular:
366.37
Ref: TM-T4252
1mg | 49,00 € | |
5mg | 109,00 € | |
10mg | 171,00 € | |
25mg | 346,00 € | |
50mg | 555,00 € | |
100mg | 791,00 € | |
1ml*10 (DMSO) | 115,00 € |
Entrega estimada en Estados Unidos, el Viernes 17 de Mayo de 2024
ML327
CAS:1883510-31-3
ML327 is a small molecule that has been shown to inhibit the growth of cancer …
Fórmula:
C19H18N4O4
Pureza:
Min. 95%
Peso molecular:
366.37 g/mol
Ref: 3D-IAD51031
1mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 21 de Junio de 2024